Koers Spring Pharmaceutical Group, Inc.
Aandelen
BYC
US84987P1057
Farmaceutische producten
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Chuan Min Li
DFI | Director of Finance/CFO | 59 | 01-01-05 |
Qiang Zhang
ADM | Chief Administrative Officer | 52 | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Ting He Yan
CEO | Chief Executive Officer | 69 | 01-01-89 |
Ji Rui Zhang
BRD | Director/Board Member | 68 | 01-01-04 |
Director/Board Member | 73 | 06-04-09 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+54,61% | 811 mld. | |
+43,42% | 640 mld. | |
-6,33% | 353 mld. | |
+20,62% | 333 mld. | |
+10,44% | 302 mld. | |
+17,74% | 246 mld. | |
+2,45% | 225 mld. | |
+12,88% | 218 mld. | |
+8,61% | 168 mld. |